Data as of Dec 12
| +0.06 / +0.59%|
The 1 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +18.23% increase from the last price of 10.15.
The current consensus among 1 polled investment analysts is to Hold stock in Albany Molecular Research Inc. This rating has held steady since December, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.